|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
AlloMek Therapeutics
| | | Phone: | (650) 814-6014 | Year Established: | 2010 | Main Contact: | Barry Hart, Ph.D., Director, Business Development | | Other Contacts: | Uday Khire, Ph.D. MBA, CEO & Founder
| |
| Company Description | AlloMek Therapeutics (formerly AlloStem Therapeutics) is a pharmaceutical company, discovers and develops targeted therapies for cancer patients. The company offers MEK kinase inhibitors that improve the biopharmaceutical properties of previous MEK inhibitors. It provides -1374, an allosteric MEK kinase inhibitor that combines potent activity against MEK1/2 kinase and against chemo-resistant ovarian cancer stem cells. | |
|
|
|
|
|